BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6730182)

  • 1. [Use of lysozyme and prodigiozan in the treatment of suppurative infections in diabetics].
    Nuzov BG
    Vestn Khir Im I I Grek; 1984 Apr; 132(4):62-5. PubMed ID: 6730182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of prodigiozan and lysozyme in ENT organ diseases].
    Brofman AV
    Zh Ushn Nos Gorl Bolezn; 1980; 1():46-51. PubMed ID: 7361524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of gentamycin in combination with prodigiozan on the immunological reactivity of the body].
    Shcherbakova EG; Rastunova GA; Vvedenskaia OI; Zhuravleva TP; Medvedeva MM
    Antibiotiki; 1979 Sep; 24(9):679-84. PubMed ID: 573585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of various indices of nonspecific bodily resistance among ginnery workers inhaling prodigiozan].
    Kuznetsov VS; Abdulkhamidov KhB; Babaian SS; Rastunova GA
    Vestn Otorinolaringol; 1987; (4):55-8. PubMed ID: 3629812
    [No Abstract]   [Full Text] [Related]  

  • 6. [X-ray therapy and various immunologic indices in the complex treatment of suppurative-inflammatory processes].
    Ogonovskiĭ VK
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):16-8. PubMed ID: 6609464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of prodigiozan and pyrimidine derivatives on the effectiveness of the antibiotic therapy of experimental infections].
    Bakirov AB
    Antibiotiki; 1979 Sep; 24(9):673-8. PubMed ID: 384893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of prodigiozan in complex treatment of endogenous infections].
    Dvurechenskaia GS; Markova EA; Fortinskaia ES
    Ter Arkh; 1980; 52(1):92-4. PubMed ID: 7368130
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prodigiozan in the therapy of destructive pulmonary tuberculosis].
    Kornilova ZKh; Svitneva AS
    Probl Tuberk; 1980 Jan; (1):30-2. PubMed ID: 7367422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute cholecystitis from the standpoint of its gerontologic features and immunologic alterations].
    Lutsenko SM; Militsa NN
    Klin Khir (1962); 1984 Apr; (4):14-8. PubMed ID: 6727156
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differential use of preformed physical factors in prodigiozan treatment of chronic salpingo-oophoritis].
    Strugatskiĭ VM; Rastorgueva VM; Tsoĭ S; Kudrina EA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1987; (2):66-8. PubMed ID: 3604127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of prodigiozan in the complex therapy of burns].
    Golosova TV; Murashova NS; Gorbuntsova RV; Gerasimova LI
    Antibiotiki; 1971; 16(8):757-61. PubMed ID: 4945153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery].
    Boĭko IN; Khavinson VKh; Morozov VG
    Voen Med Zh; 1985 Jul; (7):45-6. PubMed ID: 3901509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM; Rychnev VE
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibility of using prodigiozan to increase the efficacy of combined treatment of breast cancer].
    Shevchenko VP
    Klin Khir (1962); 1987; (5):9-12. PubMed ID: 3613441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL; Andrushchuk AA; Korzhenevskiĭ AF; Krivokhatskaia LD
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Content of total immunoglobulin E of the blood serum in patients with acute viral hepatitis A and B undergoing prodigiozan and ibuprofen treatment].
    Andreĭchin MA; Rudchik AS
    Sov Med; 1988; (12):117-8. PubMed ID: 3242111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA; Rushchak VA; Maliuk VI; Vel'tman RV; Polner RA
    Pediatr Akus Ginekol; 1979; (3):16-8. PubMed ID: 379787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of prodigiozan in the overall treatment of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Tsymbaliuk GF; Kostromina VP; Medvedeva MM
    Probl Tuberk; 1980 Jan; (1):33-6. PubMed ID: 6966060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience in using prodigiozan in the overall treatment of suppurative surgical diseases in children].
    Zhukov MD; Geĭn VV
    Klin Khir (1962); 1979 Jun; (6):38-40. PubMed ID: 379414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.